Clinical Trial Update: CX-8998 for Absence Seizures [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of CX-8998 for epilepsy (absence seizures) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• CX-8998

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2022-09-08